Regional Stocks
Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
SUPERNUS PHARM (NQ: SUPN)
6.710 USD  +0.040 (+0.60%)
Official Closing Price  /  Updated: 4:00 PM EDT, Jun 19, 2013  /  Add to My Watchlist      
View: Quote News
Press releases about SUPERNUS PHARM
 
Supernus Receives Tentative Approval for Trokendi XR(TM)
June 10, 2013
from GlobeNewswire News Releases
Supernus to Present at Two Investor Conferences
May 20, 2013
from GlobeNewswire News Releases
Supernus Pharmaceuticals Reports First Quarter 2013 Financial Results
May 13, 2013
from GlobeNewswire News Releases
Supernus Announces First Quarter 2013 Earnings Conference Call and Webcast
May 06, 2013
from GlobeNewswire News Releases
Supernus Announces Closing of $90 Million of 7.50% Convertible Senior Secured Notes Due 2019
May 06, 2013
from GlobeNewswire News Releases
Supernus Prices Offering of $75 Million of 7.50% Convertible Senior Secured Notes Due 2019
April 26, 2013
from GlobeNewswire News Releases
Supernus Announces Proposed Offering of $75 Million of Convertible Senior Secured Notes
April 24, 2013
from GlobeNewswire News Releases
Free Research Reports on CIM, JVA, MS and SUPN Issued by the Bedford Report
March 19, 2013
Note to Editors: The Following Is an Investment Opinion Being Issued by the EQUITY NEWS CIRCUIT Read More
from Marketwired News Releases
U.S. Food and Drug Administration Approved 30% More Drugs in 2012 Than the Year Previous
March 19, 2013
RDInvesting Provides Stocks Research on Protalix BioTherapeutics and Supernus Pharmaceuticals Read More
from Marketwired News Releases
Supernus Pharmaceuticals Reports Fourth Quarter 2012 and Full Year 2012 Financial Results
March 14, 2013
from GlobeNewswire News Releases
Supernus Announces Year-End and Fourth Quarter 2012 Earnings Conference Call and Webcast
March 07, 2013
from GlobeNewswire News Releases
Supernus Launches Oxtellar XR(TM) in the United States
February 01, 2013
from GlobeNewswire News Releases
Supernus Appoints Victor Vaughn as Senior Vice President of Sales
January 14, 2013
from GlobeNewswire News Releases
Perfect Trade Setups, How to Play SUPN, MLNX, WIN and MDLZ
December 19, 2012
from Marketwired News Releases
The Real Story Behind SUPN, MLNX, WIN and MDLZ
December 18, 2012
from Marketwired News Releases
Free Research Reports on CBK, RIC, SUPN and NTLS Issued by the Bedford Report
December 03, 2012
Note to Editors: The Following Is an Investment Opinion Being Issued by the EQUITY NEWS CIRCUIT Read More
from Marketwired News Releases
Supernus Announces Pricing of Public Offering
November 29, 2012
from GlobeNewswire News Releases
Supernus Announces Positive Phase IIb Results on SPN-810 and Decision to Advance to Late Stage Development
November 20, 2012
from GlobeNewswire News Releases
Supernus Receives Three Years of Market Exclusivity for Oxtellar XR(TM)
November 19, 2012
from GlobeNewswire News Releases
Semi-Annual Changes to the NASDAQ Biotechnology Index
November 12, 2012
from GlobeNewswire News Releases
Supernus Pharmaceuticals Reports Third Quarter 2012 Financial Results
November 07, 2012
from GlobeNewswire News Releases
Supernus Announces Issuance of Two Patents Covering Trokendi XR(TM)
November 05, 2012
from GlobeNewswire News Releases
Supernus Announces Resignation of Board Member
October 31, 2012
from GlobeNewswire News Releases
Supernus Receives FDA Approval for Oxtellar XR(TM) in Epilepsy
October 22, 2012
Second Product Approval Following Tentative Approval of Trokendi XR(TM) Read More
from GlobeNewswire News Releases
Supernus to Present at Two Investor Conferences in September 2012
August 29, 2012
from GlobeNewswire News Releases
Supernus Pharmaceuticals Reports Second Quarter 2012 Financial Results
August 10, 2012
from GlobeNewswire News Releases
Supernus Appoints Dr. Stefan Schwabe, MD, PhD as Exec. VP R&D and Chief Medical Officer
July 20, 2012
from GlobeNewswire News Releases
Supernus Provides Update on the Launch of Its Two Epilepsy Products Trokendi XR(TM) and SPN-804
July 13, 2012
from GlobeNewswire News Releases
Supernus Receives Tentative Approval of Trokendi XR(TM) From FDA
June 26, 2012
from GlobeNewswire News Releases
Supernus Pharmaceuticals Reports First Quarter 2012 Financial Results
June 07, 2012
from GlobeNewswire News Releases
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here